MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

LEQEMBI® (lecanemab), a treatment for Alzheimer's disease, is now available in South Korea, expanding access to innovative care

A New Production Line Dedicated to Sterile Hyaluronic Acid Has Been Inaugurated by HTL Biotechnology

09 Jun 2025

On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high...

Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

$Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia$

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

Rebeca Villarreal-Barragan, MBA, Appointed Head of Clinical Operations at 3T Biosciences

FIZE Medical, in an exclusive deal with Asahi Kasei Medical, has launched the FIZE kUO® System in Japan

Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership

By Packaging Compliance Labs
Packaging Compliance Labs
30 Sep 2026

Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

By Ro
Ro
30 Sep 2026

Cresilon launched next-generation TRAUMAGEL.

By Cresilon
Cresilon
29 Sep 2026

SHARx Focuses on Rx Continuity for Employers and Patients as Customs Requirements Change

By SHARx
SHARx
28 Sep 2026

Zifo Unveils Vision for an AI-Driven Scientific Semantic Layer in Biopharma

By Zifo
Zifo
28 Sep 2026

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

By ImmunoScape Pte. Ltd.
ImmunoScape Pte. Ltd.
23 Sep 2026

Most Popular

PBS Biotech Secures $17M and Expands Leadership to Accelerate Next-Gen Cell Therapies

By PBS Biotech Inc

Jan 06
Why the Pharmacy System Rewards the Wrong Results: It Is Working as Designed

By SHARx

Aug 04
LIB Therapeutics Announces Positive Lerodalcibep Results from Two Phase 3 LIBerate Studies

By LIB Therapeutics Inc

May 29

October 2026

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

LEQEMBI® (lecanemab), a treatment for Alzheimer's disease, is now available in South Korea, expanding access to innovative care

A New Production Line Dedicated to Sterile Hyaluronic Acid Has Been Inaugurated by HTL Biotechnology

Biologic Therapy Improves Pregnancy Outcomes in High-Risk Antiphospholipid Syndrome Patients, Says HSS

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

Rebeca Villarreal-Barragan, MBA, Appointed Head of Clinical Operations at 3T Biosciences

FIZE Medical, in an exclusive deal with Asahi Kasei Medical, has launched the FIZE kUO® System in Japan

Packaging Compliance Labs enters pharmaceutical testing market with dedicated lab and expert leadership

Ro and Novo announce research collaboration to generate first-of-its-kind real-world evidence on the Wegovy® pill

Cresilon launched next-generation TRAUMAGEL.

SHARx Focuses on Rx Continuity for Employers and Patients as Customs Requirements Change

Zifo Unveils Vision for an AI-Driven Scientific Semantic Layer in Biopharma

ImmunoScape Appoints Peter Olagunju as Chief Executive Officer

Most Popular

PBS Biotech Secures $17M and Expands Leadership to Accelerate Next-Gen Cell Therapies

Why the Pharmacy System Rewards the Wrong Results: It Is Working as Designed

LIB Therapeutics Announces Positive Lerodalcibep Results from Two Phase 3 LIBerate Studies

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter